Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2013 Mar;65(3):441–447. doi: 10.1002/acr.21841

Table 5.

HsCRP level and cardiovascular risk factors in patients studied

Risk factors hsCRP ≤3.0mg/L
(N=207)
hsCRP >3.0mg/L
(N=82)
*P
Age, years 39.3±15 38.9±13 0.09
Women 201 (97%) 72 (88%) 0.001
Smoking ≥3 years 19 (9%) 14 (17%) 0.04
Diabetes mellitus 3 (1%) 5 (6%) 0.02
Hypertension 39 (19%) 20 (24%) 0.28
LDL/HDL-chol 1.72±0.69 2.22±2.0 0.06
Total Chol/HDL-chol 3.10±0.87 3.82±2.80 0.03
TG/HDL-chol 0.90±0.60 1.41±2.3 0.045
**Atherogenic index −0.123±0.26 −0.004±0.32 0.01
BMI, mg/m2 21.8±3.7 22.2±3.8 0.17
BMI >27mg/m2 19 (9%) 9 (11%) 0.38
History of arterial thrombosis 12 (6%) 11 (13%) 0.01
*

P values adjusted for SLE disease activity scores and serum creatinine by regression

**

Atherogenic index = Log(triglyceride/HDL-cholesterol)

CRP = C-reactive protein; LDL = low density lipoprotein; HDL = high density lipoprotein; Chol = cholesterol; TG = triglyceride; BMI = body mass index